Indapta Therapeutics

1 follower

‌

Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

Mark W. Frohlich

CEO

Mark W. Frohlich

Collapse

Robert Sikorski

Acting Chief Medical Officer

Austin Bigley

VP, Research

Ronald Martell

Co-Founder, Executive Chairman

Moya Daniels

Regulatory Affairs Consultant

Teams

View all

Leadership Team

3 members

Board of Directors

6 members

CEO and Executive Team

1 members

Founding Team

1 members

Discover similar companies

Entos

1 follower

Lodo Therapeutics

1 follower

Protein Metrics

2 followers

Shiru

3 followers

AsclepiX Therapeutics

1 follower